Skip to main content
Home
FULL MENU Close Menu
Home
Home

HT Staff

News

FDA approves biosimilar rituximab for NHL

Author:
HT Staff
Publish date: November 29, 2018

The U.S.

  • Read More

News

EC approves product for hemophilia A

Author:
HT Staff
Publish date: November 29, 2018

The European Commission (EC) has approved damoctocog alfa pegol (Jivi®), a recombinant human factor VIII therapy. Damoctocog alfa pegol (formerly...

  • Read More

News

EC approves mogamulizumab for MF, SS

Author:
HT Staff
Publish date: November 28, 2018

The European Commission (EC) has granted marketing authorization for mogamulizumab (Poteligeo), a humanized monoclonal antibody directed against...

  • Read More

News

Canada expands approval for antihemophilic factor

Author:
HT Staff
Publish date: November 28, 2018

Health Canada has extended the approved indication for Adynovate, a recombinant pegylated factor VIII (FVIII) product, in patients with hemophilia...

  • Read More

News

Pegfilgrastim biosimilar approved by EC

Author:
HT Staff
Publish date: November 28, 2018

The European Commission (EC) has granted marketing authorization for Sandoz’s pegfilgrastim product Ziextenzo®, a biosimilar of Amgen’s Neulasta...

  • Read More

News

Older people with CHIP are safe donor source for HSCT

Author:
HT Staff
Publish date: November 27, 2018

New research suggests older individuals with clonal hematopoiesis of indeterminate potential (CHIP) are a safe donor source for allogeneic...

  • Read More

News

EC approves pegfilgrastim biosimilar

Author:
HT Staff
Publish date: November 27, 2018

The European Commission (EC) has approved Mundipharma’s pegfilgrastim product Pelmeg, a biosimilar of Amgen’s Neulasta. Pelmeg is approved for...

  • Read More

News

FDA grants priority review to quizartinib

Author:
HT Staff
Publish date: November 27, 2018

The U.S.

  • Read More

News

ASH expands late-breaking abstract session

Author:
HT Staff
Publish date: November 26, 2018

An additional presentation has been added to the late-breaking abstract session of the 2018 ASH Annual Meeting. The session was expanded from six...

  • Read More

News

Americans concerned about cost of cancer care

Author:
HT Staff
Publish date: November 20, 2018

A recent survey suggests Americans are nearly as worried about the cost of a cancer diagnosis as they are about dying from cancer. The cost of...

  • Read More

News

CHMP backs blinatumomab for MRD

Author:
HT Staff
Publish date: November 18, 2018

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding marketing authorization for...

  • Read More

News

Eltrombopag approved as first-line SAA therapy

Author:
HT Staff
Publish date: November 17, 2018

The U.S.

  • Read More

News

Quick FDA approval for brentuximab vedotin in PTCL

Author:
HT Staff
Publish date: November 16, 2018

The U.S.

  • Read More

News

FDA approves generic drugs for APL

Author:
HT Staff
Publish date: November 16, 2018

The U.S.

  • Read More

News

FDA approves generic decitabine for MDS

Author:
HT Staff
Publish date: November 16, 2018

The U.S. Food and Drug Administration has approved Lupin’s decitabine product, a generic version of Otsuka Pharmaceutical Co.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close